NeuroMetrix, Inc. Announces Date for First Quarter 2023 Financial Results Conference Call
28 Aprile 2023 - 3:21PM
NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to
issue its 2023 first quarter financial results before the opening
of the market on May 3, 2023. The Company will host a conference
call at 8:00 a.m., Eastern Time on May 3, 2023 to discuss its
financial results as well as business developments affecting the
Company.
For participants who wish to access the Earnings Call live via
telephone and be able to ask questions, please register in advance
here. Upon registering, a dial-in and unique PIN will be provided
on screen and via email to join the call. An audio-only webcast of
the call, along with the earnings press release and accompanying
condensed financial statements, may be accessed in the Investors
section of the Company’s website at www.NeuroMetrix.com. Following
the conference call, a replay of the call will be available for one
year on the Company's Investors section of the website.
About NeuroMetrix
NeuroMetrix is an innovation-driven company with a mission to
improve individual and population health through novel medical
devices and technology solutions for neurological disorders and
pain syndromes. The Company has three commercial products.
DPNCheck® is a diagnostic device that provides rapid, point-of-care
detection of peripheral neuropathies. ADVANCE® is a diagnostic
device that provides automated, in-office nerve conduction studies
for the evaluation of focal neuropathies. Quell® Fibromyalgia
is a wearable neuromodulator that is the only FDA-authorized
medical device to help reduce the symptoms of fibromyalgia. For
more information, visit www.NeuroMetrix.com.
NeuroMetrix, Inc.Thomas T. HigginsSVP and Chief Financial
Officerneurometrix.ir@neurometrix.com
Source: NeuroMetrix, Inc.
Grafico Azioni NeuroMetrix (NASDAQ:NURO)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni NeuroMetrix (NASDAQ:NURO)
Storico
Da Mag 2023 a Mag 2024